Peter R. Jackson

1.3k total citations
37 papers, 1.1k citations indexed

About

Peter R. Jackson is a scholar working on Epidemiology, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Peter R. Jackson has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Surgery and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Peter R. Jackson's work include Trypanosoma species research and implications (10 papers), Lipoproteins and Cardiovascular Health (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Peter R. Jackson is often cited by papers focused on Trypanosoma species research and implications (10 papers), Lipoproteins and Cardiovascular Health (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Peter R. Jackson collaborates with scholars based in United Kingdom and United States. Peter R. Jackson's co-authors include Geoffrey T. Tucker, G. Storey, David W. Holt, Mohsen Aarabi, Amin Rostami‐Hodjegan, GT Tucker, Michael G. Pappas, Brian D. Hansen, H.F. Woods and Lawrence E. Ramsay and has published in prestigious journals such as Science, Journal of the American Academy of Child & Adolescent Psychiatry and Biochemical Pharmacology.

In The Last Decade

Peter R. Jackson

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter R. Jackson United Kingdom 18 314 225 217 195 144 37 1.1k
Juan J.L. Lertora United States 24 199 0.6× 156 0.7× 285 1.3× 222 1.1× 93 0.6× 49 1.7k
Sylvia M. Wallace Canada 21 252 0.8× 156 0.7× 177 0.8× 334 1.7× 41 0.3× 44 1.6k
G Cheymol France 19 491 1.6× 59 0.3× 248 1.1× 143 0.7× 88 0.6× 97 1.4k
Douglas C. Throckmorton United States 17 169 0.5× 259 1.2× 490 2.3× 122 0.6× 154 1.1× 28 1.7k
Thomas C. Dowling United States 23 396 1.3× 68 0.3× 168 0.8× 230 1.2× 65 0.5× 66 1.6k
J. K. Faulkner United Kingdom 16 138 0.4× 74 0.3× 130 0.6× 207 1.1× 56 0.4× 32 1.1k
John McEwen United Kingdom 21 147 0.5× 65 0.3× 138 0.6× 90 0.5× 252 1.8× 73 1.4k
Mario L. Rocci United States 24 197 0.6× 140 0.6× 326 1.5× 99 0.5× 218 1.5× 73 2.1k
Hans Ericsson Sweden 23 361 1.1× 42 0.2× 291 1.3× 103 0.5× 163 1.1× 71 1.5k
Eduardo L. Mariño Spain 16 198 0.6× 82 0.4× 165 0.8× 58 0.3× 113 0.8× 109 1.1k

Countries citing papers authored by Peter R. Jackson

Since Specialization
Citations

This map shows the geographic impact of Peter R. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Jackson more than expected).

Fields of papers citing papers by Peter R. Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Jackson. The network helps show where Peter R. Jackson may publish in the future.

Co-authorship network of co-authors of Peter R. Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Jackson. A scholar is included among the top collaborators of Peter R. Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Jackson. Peter R. Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Peter R.. (2023). 7.2 The Multigenerational Impact of Substance Use Disorder–Related Stigma and How to Address It With Families. Journal of the American Academy of Child & Adolescent Psychiatry. 62(10). S12–S12. 1 indexed citations
2.
Weatherley, Nicholas & Peter R. Jackson. (2010). The new Sheffield risk and benefit tables for the elderly. QJM. 104(1). 3–12. 7 indexed citations
3.
Barker, Anthony T., et al.. (2007). The effect of GSM and TETRA mobile handset signals on blood pressure, catechol levels and heart rate variability. Bioelectromagnetics. 28(6). 433–438. 31 indexed citations
4.
Aarabi, Mohsen & Peter R. Jackson. (2007). Prevention of coronary heart disease with statins in UK South Asians and Caucasians. European Journal of Cardiovascular Prevention & Rehabilitation. 14(2). 333–339. 4 indexed citations
5.
Aarabi, Mohsen & Peter R. Jackson. (2005). Predicting coronary risk in UK South Asians: an adjustment method for Framingham-based tools. European Journal of Cardiovascular Prevention & Rehabilitation. 12(1). 46–51. 36 indexed citations
6.
Jackson, Peter R., et al.. (2001). Statins for primary prevention: at what coronary risk is safety assured?. British Journal of Clinical Pharmacology. 52(4). 439–446. 24 indexed citations
7.
Haq, Iftikhar Ul, Erica J. Wallis, Peter R. Jackson, W W Yeo, & Lawrence E. Ramsay. (1999). Implication of recent trials with b-hydroxy-b-methylglutaryl coenzyme A reductase inhibitors for hypertension management. Journal of Hypertension. 17(11). 1641–1646. 1 indexed citations
8.
Rostami‐Hodjegan, Amin, et al.. (1996). Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment. Pharmacogenetics. 6(2). 121–149. 100 indexed citations
9.
Haq, Iftikhar Ul, Peter R. Jackson, W W Yeo, & L E Ramsay. (1996). Implications of recent trials with lipid-lowering drugs for hypertension management. Journal of Hypertension. 14(12). 1502–1502. 1 indexed citations
10.
Rostami‐Hodjegan, Amin, Peter R. Jackson, & Geoffrey T. Tucker. (1994). Sensitivity of Indirect Metrics for Assessing “Rate” in Bioequivalence Studies—Moving the “Goalposts” or Changing the “Game”. Journal of Pharmaceutical Sciences. 83(11). 1554–1557. 38 indexed citations
11.
Yeo, W W, et al.. (1994). 8 Effect of dose adjustment on enalapril-induced cough and the response to inhaled capsaicin. Journal of Hypertension. 12(11). 1311–1311. 1 indexed citations
12.
Jackson, Peter R., Alan R. Boobis, & Geoffrey T. Tucker. (1991). Phenotype or genotype. British Journal of Clinical Pharmacology. 31(1). 119–120. 2 indexed citations
13.
Jackson, Peter R., et al.. (1990). Case report: Subcutaneous herniation of gall-bladder with spontaneous cholecystocutaneous fistula. Clinical Radiology. 42(4). 283–284. 19 indexed citations
14.
Shetty, Hitesh, et al.. (1990). Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprolol. Biochemical Pharmacology. 40(7). 1637–1644. 47 indexed citations
15.
Jackson, Peter R., et al.. (1986). Effects of indomethacin and sulindac on blood pressure of hypertensive patients.. BMJ. 292(6525). 934.2–935. 13 indexed citations
16.
Jackson, Peter R., Michael G. Pappas, & Brian D. Hansen. (1985). Fluorogenic Substrate Detection of Viable Intracellular and Extracellular Pathogenic Protozoa. Science. 227(4685). 435–438. 76 indexed citations
17.
Jackson, Peter R., et al.. (1985). Side-effects of ?-blockers assessed using visual analogue scales. European Journal of Clinical Pharmacology. 28(S1). 93–96. 6 indexed citations
18.
Hockmeyer, Wayne T., et al.. (1985). Identification of Pathogenic Leishmania Promastigotes by DNA: DNA Hybridization with Kinetoplast DNA Cloned into E. Coli Plasmids *. American Journal of Tropical Medicine and Hygiene. 34(2). 257–265. 26 indexed citations
19.
Holt, David W., Geoffrey T. Tucker, Peter R. Jackson, & G. Storey. (1983). Amiodarone pharmacokinetics. American Heart Journal. 106(4). 840–847. 336 indexed citations
20.
Jackson, Peter R., Geoffrey T. Tucker, & H.F. Woods. (1982). Altered plasma drug binding in cancer: Role of α1-acid glycoprotein and albumin. Clinical Pharmacology & Therapeutics. 32(3). 295–302. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan J.L. Lertora Breakdown of academic impact, for papers by Sylvia M. Wallace Breakdown of academic impact, for papers by G Cheymol Breakdown of academic impact, for papers by Douglas C. Throckmorton Breakdown of academic impact, for papers by Thomas C. Dowling Breakdown of academic impact, for papers by J. K. Faulkner Breakdown of academic impact, for papers by John McEwen Breakdown of academic impact, for papers by Mario L. Rocci Breakdown of academic impact, for papers by Hans Ericsson Breakdown of academic impact, for papers by Eduardo L. Mariño
Rankless by CCL
2026